trial · primary record
Tarlatamab
Small Cell Lung Cancer
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 35 |
| Primary completion | 2030-02 |
| Primary endpoint | Intracranial overall response rate (ORR) |
| Registry ID | NCT07402343 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:41:50.719Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07402343
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.